Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × pomalidomide × Plasma cell × Clear all

Status

Completed 55 Active not recruiting 36 Terminated 32 Recruiting 30 Unknown 14 Withdrawn 8 Not yet recruiting 6 No longer available 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

elotuzumab 4 Panobinostat 2 Lenalidomide 2 Dexamethasone 2 Bortezomib 2 selinexor 1 pomalidomide 1 plerixafor 1 fludarabine phosphate 1 carfilzomib 1 Whole-Body Irradiation 1 Tacrolimus 1 Prednisone 1 Mycophenolic Acid 1 Melphalan 1 Cytarabine 1 Crizotinib 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03723096 2018-12-20

Expanded Access for CC-4047

Celgene

No longer available

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡